Substituted quinazoline derivatives for use in gastrointestinal diseases
US5064833A · kind A · utility
43Cited by
14References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 8, 1990 |
| Grant date | Nov 12, 1991 |
| Priority date | — |
| Expiry date | May 8, 2010 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D239/95
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
2,4-diaminoquinazoline compounds are inhibitors of the H.sup.+ K.sup.+ ATPase enzyme and useful for the treatment of diseases of the stomach based on excessive gastric acid secretion. A compound of the invention is 2-[2-methyl-4-fluorophenyl)amino]-4-(N-methylphenylamino)quinazoline.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.